Guy Cameron


PhD, Bbiomedsci(hons)

Publications


Download BibTeX


Original Articles


Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap


Tu X, Kim RY, Brown AC, de Jong E, Jones-Freeman B, Ali MK, Gomez HM, Budden KF, Starkey MR, Cameron GJM, Loering S, Nguyen DH, Nair PM, Haw TJ, Alemao CA, Faiz A, Tay HL, Wark PAB, Knight DA, Foster PS, Bosco A, Horvat JC, Hansbro PM, Donovan C.


J Allergy Clin Immunol, S0091-6749(22), 2022, pp. 00706-0


Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain


Loering S, Cameron GJM, Bhatt NP, Belz GT, Foster PS, Hansbro PM, Starkey MR.


Immunol Cell Biol, vol. 99(5), 2020, pp. 542-551


Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury


Cameron GJM, Cautivo KM, Loering S, Jiang SH, Deshpande AV, Foster PS, McKenzie ANJ, Molofsky AB, Hansbro PM, Starkey MR.


Front Immunol, vol. 10(1), 2019, p. 826


Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease


Donovan C, Starkey MR, Kim RY, Rana BMJ, Barlow JL, Jones B, Haw TJ, Mono Nair P, Budden K, Cameron GJM, Horvat JC, Wark PAB, Foster PS, McKenzie ANJ, Hansbro PM.


J Leukoc Biol, vol. 105(1), 2019, pp. 143-150


IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis


Starkey MR, Plank MW, Casolari P, Papi A, Pavlidis S, Guo Y, Cameron GJM, Haw TJ, Tam A, Obiedat M, Donovan C, Hansbro NG, Nguyen DH, Nair PM, Kim RY, Horvat JC, Kaiko GE, Durum SK, Wark PAB, Sin DD, Caramori G, Adcock IM, Foster PS, Hansbro PM.


Eur Respir J, vol. 54(1), 2019, p. 1800174



Reviews


Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury


Cameron GJM, Jiang SH, Loering S, Deshpande AV, Hansbro PM, Starkey MR.


J Pathol, vol. 248(1), 2019, pp. 9-15


Lung development and emerging roles for type 2 immunity


Loering S, Cameron GJM, Starkey MR, Hansbro PM.


J Pathol, vol. 247(5), 2019, pp. 686-696